we conclude that the response of patients with metastatic prostate cancer to exogenous testosterone is related to the mass and endocrine treatment status , and that exogenous testosterone can stimulate prostatic neoplasms that proliferate in the absence of normal endogenous testosterone levels .
C0039601
testosterone
C0033578
prostatic